Chai Discovery secures four major pharma deals this summer for its biological AI platform. The company capitalizes on a sudden surge in enterprise pharmaceutical spending on artificial intelligence tools for drug discovery. This rapid commercial traction highlights the growing maturation and market acceptance of generative AI in biotechnology.
Opening Kapyn…